MedPath

Comparative effectiveness of Itrifal ustukhuddus and Sharbat e Sadar in the treatment of Chronic Sinusitis

Phase 2
Conditions
Health Condition 1: J329- Chronic sinusitis, unspecified
Registration Number
CTRI/2024/07/071703
Lead Sponsor
State Unani Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of any sex, aged 18-50 years

2. Duration of the disease greater than 12 week.

3. Patient having at least two out of four cardinal symptoms i.e., facial pain/pressure,

hyposmia/anosmia, nasal obstruction, and nasal discharge for at least 12 consecutive

weeks

4. Patient having any of the following symptoms like rhinorrhoea, nasal congestion, frontal

headache, nasal itching, impaired sense of smell and frequent sneezing for more than 12

weeks.

5. Positive X-ray PNS finding like Thickened mucosal lining, opacity of sinus.

Exclusion Criteria

1. Patient aged below 18 years or above 50 years

2. Patient with deviated nasal septum

3. Local pathology such as mucocele, cyst, antrochoanal polyp, facial trauma.

4. Diabetes mellitus and any other illness requiring long term treatment.

5. Pregnant or Lactating Women.

6. Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction

7. Known cases of Immunocompromised states like HIV/ AIDS, etc. or Malignancies

8. Patient not willing to attend regular treatment and follow-up for the entire duration of

study

9. Mentally retarded patients.

10. Patient having history of any surgery of nose or paranasal sinuses.

11. Patient having history of trauma to nose or sinus area.

12. Patient of pulmonary Koch’s or having history of epistaxis.

13. Any medical condition where physician feels that participation in the study could be

detrimental to patient’s well- being.

14. Alcoholic and Drug addicted patient.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath